SEOUL, South Korea--(BUSINESS WIRE)--
SELVAS AI (KOSDAQ:108860), an artificial intelligence company, will receive CES 2018 Innovation Award for its AI disease prediction solution “Selvy Checkup” at the CES (Consumer Electronics Show) 2018, one of the largest global consumer electronics tradeshows in Las Vegas, Nevada, USA in January next year.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171109005620/en/
SELVAS AI, an artificial intelligence company, will receive CES 2018 Innovation Award for its AI disease prediction solution "Selvy Checkup" at the CES 2018 (Graphic: Business Wire)
Winners of CES Innovation Awards are chosen by Consumer Technology Association (CTA) and Industrial Designers Society of America (IDSA) which evaluate products in 28 categories in terms of technology, innovativeness and design.
Selvy Checkup is a medical service that predicts the probabilities of incidence within two or three years for six most common cancers including lung and liver cancers and major adult diseases including cardio-cerebrovascular disease and diabetes. It is provided as part of health checkup.
The service was developed through joint research by big data analysts and clinical research physicians in various fields. It is considered one of the best medical AI solutions. The CES 2018 award is meaningful to medical and IT industries in that it is a worldwide recognition of the superb technology and excellent innovativeness of the service jointly researched by large hospitals and SELVAS AI.
The incidence of adult diseases is rising due to rapid population aging and unhealthy habits of the modern life. Adult diseases are one of the leading causes of death in the world, but they are preventable and curable at an early stage if they are predicted and managed. Selvy Checkup has been selected as a CES 2018 Innovation Award winner in the category of “Tech for a Better World” in recognition of its intelligent disease forecasting system which contributes to the efficient control of adult diseases and the promotion of people’s health.
SELVAS AI will exhibit its products at a booth (Hall A-D Sands #43849) in the CES 2018 from Jan. 9-12 in Las Vegas, USA.
SELVAS AI
SELVAS AI is an artificial intelligence company that does AI-related businesses in diverse fields including medical care, finance, automobiles and assistive technology on the basis of machine learning techniques. It possesses core AI technologies such as voice, handwriting and image intelligences and AI convergence technology which combines those core technologies. All the technologies of SELVAS AI are based on machine learning platform.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171109005620/en/
